InvestorsHub Logo
Followers 0
Posts 294
Boards Moderated 0
Alias Born 09/15/2016

Re: None

Tuesday, 08/25/2020 1:42:11 PM

Tuesday, August 25, 2020 1:42:11 PM

Post# of 3647
Venturis Therapeutics: A legacy of failure & unaccountability

Here we are, three months past the date which the bylaws of Venturis Therapeutics state the 2020 shareholders meeting should have taken place (but didn't). With Venturis having suffered a catastrophic 7-figure adverse judgment in binding arbitration at the hands of its former CEO, Daniel Montano, it's clear to me it's just a matter of time before Venturis is liquidated or declares bankruptcy. I believe Venturis is on the verge of collapsing under the weight of its lies and deceit. And rather than addressing any of the concerns of shareholders, all the company and its supporters seem able to do is talk about events of 7 years ago, about the former CEO Dan Montano who hasn't been in the company for this same period, and refuse to address one simple question:

Why has Venturis Therapeutics failed to run a single clinical trial since 2007?

We shareholders never, ever, ever get an answer to that question. Under the leadership of Calvin Wallen III, who has been accused by the U.S. government of being a crook and is awaiting trial for having allegedly stolen $14 million from his previous company, Venturis Therapeutics has nothing but a legacy of failure, lack of accountability, and a repeated history of false statements made by the company and its representatives. It's pathetic.

It's all over soon enough. I've already taken my write-off of my worthless shares. But I refuse to stay silent, and I refuse to go away quietly. There will be accountability, one way or another.

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.